Detalhe da pesquisa
1.
Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas.
Proc Natl Acad Sci U S A
; 113(11): 3030-5, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26929372
2.
p32 is a novel mammalian Lgl binding protein that enhances the activity of protein kinase Czeta and regulates cell polarity.
J Cell Biol
; 178(4): 575-81, 2007 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-17682048
3.
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events.
Oncol Res Treat
; 44(10): 547-556, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515215
4.
Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers.
Cancer Discov
; 7(9): 1030-1045, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28526733
5.
An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin.
Cancer Res
; 73(19): 6024-35, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23928993